ALVO
Alvotech
NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.30
-6.25% today
Updated 2026-04-29
Market cap
$1.03B
P/E ratio
33.00
P/S ratio
1.75x
EPS (TTM)
$0.10
Dividend yield
—
52W range
$3 – $12
Volume
0.6M
Alvotech (ALVO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-88.55M | $-74.30M | $-228.17M | $-312.39M | $-312.19M | $-236.84M | $-50.20M |
| Capital expenditures | $8.05M | $11.98M | $40.63M | $49.00M | $46.47M | $57.00M | $64.47M |
| Depreciation | $14.61M | $16.42M | $18.20M | $20.41M | $24.21M | $31.30M | — |
| Stock-based comp | $22.30M | $-5.46M | $-22.32M | $10.32M | $18.03M | $7.63M | $17.38M |
| Free cash flow | $-96.60M | $-86.28M | $-268.80M | $-361.39M | $-358.66M | $-293.84M | $-114.67M |
| Investing cash flow | $-12.88M | $-16.90M | $-40.63M | $-63.54M | $-46.34M | $-18.87M | — |
| Financing cash flow | $116.37M | $55.40M | $254.83M | $424.91M | $301.32M | $297.31M | — |
| Dividends paid | — | — | — | $184.76M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |